Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UNITED THERAPEUTICS (UTHR) Other Non-Current Assets: 2009-2024

Historic Other Non-Current Assets for UNITED THERAPEUTICS (UTHR) over the last 16 years, with Dec 2024 value amounting to $222.1 million.

  • UNITED THERAPEUTICS's Other Non-Current Assets rose 43.03% to $262.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $262.6 million, marking a year-over-year increase of 43.03%. This contributed to the annual value of $222.1 million for FY2024, which is 46.31% up from last year.
  • UNITED THERAPEUTICS's Other Non-Current Assets amounted to $222.1 million in FY2024, which was up 46.31% from $151.8 million recorded in FY2023.
  • UNITED THERAPEUTICS's 5-year Other Non-Current Assets high stood at $222.1 million for FY2024, and its period low was $108.2 million during FY2021.
  • Over the past 3 years, UNITED THERAPEUTICS's median Other Non-Current Assets value was $151.8 million (recorded in 2023), while the average stood at $162.7 million.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first tumbled by 36.32% in 2021, then surged by 46.31% in 2024.
  • UNITED THERAPEUTICS's Other Non-Current Assets (MRY) stood at $169.9 million in 2020, then crashed by 36.32% to $108.2 million in 2021, then increased by 5.64% to $114.3 million in 2022, then surged by 32.81% to $151.8 million in 2023, then surged by 46.31% to $222.1 million in 2024.
  • Its last three reported values are $222.1 million in FY2024, $151.8 million for FY2023, and $114.3 million during FY2022.